Genzyme Insists $69 Per Share Too Low Friday, October 22, 3:32 PM ET, by Market News Video Staff The Board of Directors for Genzyme Corp. (GENZ) continues to rebuff the hostile takeover efforts ...
AMGN, BIIB Initiated at Sell Thursday, November 4, 12:51 PM ET, by Market News Video Staff Coverage of both Amgen (AMGN) and Biogen Idec (BIIB) was initiated at Goldman Sachs (GS) ...
COV Beats Expectations Tuesday, November 9, 11:42 AM ET, by Market News Video Staff Irish medical device maker Covidien (COV) posted a surge in fourth quarter earnings that beat ...
HGSI Falls on Benlysta Concerns Friday, November 12, 11:45 AM ET, by Market News Video Staff Human Genome Sciences (HGSI) shares are falling Friday after documents showed the Food and Drug ...
HGSI Awaits FDA Panel Recommendation Tuesday, November 16, 12:21 PM ET, by Market News Video Staff Human Genome Sciences (HGSI) shares were halted Tuesday while a Food and Drug Administration advisory ...
In trading on Wednesday, shares of Human Genome Sciences Inc. (NASDAQ:HGSI) crossed above their 200 day moving average of $26.68, changing hands as high as $26.81 per share. Human Genome Sciences Inc. shares are currently trading up about 2.4% on the day. The chart below shows the one year performance of HGSI shares, versus its 200 day moving average:
Looking at the chart above, HGSI's low point in its 52 week range is $20.65 per share, with $30.48 as the 52 week high point — that compares with a last trade of $26.52.
HGSI operates in the Biotechnology sector, among companies like Biogen Idec Inc (NASDAQ:BIIB) which is off about 0.3% today, and Thermo Fisher Scientific Inc (NYSE:TMO) trading lower by about 0.9%. Below is a three month price history chart comparing the stock performance of HGSI, versus BIIB and TMO.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AboveAverageBIIBBelowBiotechnologyChannelETFsFirstGenomeHGSIHumanMovingNASDAQNYSEPortfolioSciencesScientificWednesdayaboutaboveamongassetaveragechartcompaniescompletelycurrentlydesignedgrowthhandshighhistorymovingoperatesotherperformancepointportfoliopricerangesharesharesstockstermstradingversusweekwhatwhichwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Analyst Moves: SBUX, NDSN
Daily Dividend Report: KFT, MRK, C, WRB, DCI
Analyst Moves: SBUX, NDSN
Weekly Market Wrap: May 11, 2012
Week Ahead Market Report: May 14, 2012
Weekly Market Wrap: May 18, 2012
